Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Dear-Doctor Letter for Edaravone Issued
November 11, 2002
- BD Places Great Importance on Social Contribution: President Cohen
November 11, 2002
- BUSINESS NEWS IN BRIEF
November 4, 2002
- BUSINESS BULLETIN
November 4, 2002
- Sysmex: FY2002 Half-year Profit Forecasts Revised Upward
November 4, 2002
- RESEARCH & DEVELOPMENT BULLETIN
November 4, 2002
- Eiken: FY2002 Profit Forecasts Revised Downward
November 4, 2002
- Shionogi Licenses Patents on BNP to Kyowa Medex
November 4, 2002
- MEET THE LEADERS (9)
November 4, 2002
- Roche to Launch Fully Automated Gene Detection Module in 2004
November 4, 2002
- REGULATORY BULLETIN
November 4, 2002
- DIAGNOSTIC NEWS IN BRIEF
November 4, 2002
- Kissei Licenses Novel Antidiabetic Agent to GSK
November 4, 2002
- NEW PRODUCTS
November 4, 2002
- Kowa Developing Anti-inflammatory Drugs with Pharmacopoeia of the US
November 4, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
November 4, 2002
- Expecting Synergism in Collaboration with Ranbaxy: Mr Yamaguchi of Nippon Chemiphar
November 4, 2002
- Law on New Drug Organization to Be Presented to Diet
November 4, 2002
- Benesis to Concentrate on Stable Supply of Safe Blood Products
November 4, 2002
- Insurer Regrouping to Make Medical Fees Vary from One Prefecture to Another: Korosho Official
November 4, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…